Veracyte, Inc. (VCYT) — Fair Value Analysis
Base-case fair value (P50): $60.53 · Current price: $53.25 · Verdict: Fairly Valued
The Verdict on VCYT
VERACYTE INC (VCYT) is currently assessed as Fairly Valued based on our proprietary Monte Carlo simulations. Trading at $53.25, VCYT aligns closely with its median fair value (P50) of $60.53. This indicates that the market price is largely reflective of the company's intrinsic value, with our models suggesting a modest potential +13.7% upside from current levels. The simulations, which project thousands of forward scenarios, position VCYT's current valuation squarely within the expected range, suggesting neither a significant overvaluation nor undervaluation at this juncture. Investors should note this tight alignment between $53.25 and our P50 fair value estimate.
How VCYT stacks up against peers
Our analysis places VCYT in an average quality tier, reflecting its operational and financial health relative to peers, despite the sector being unspecified for direct comparison. This average standing supports the Fairly Valued verdict derived from our Monte Carlo models. While companies with superior quality tiers might command a higher premium, or those with lower tiers a discount, VCYT's current trading at $53.25 against an average quality profile reinforces the market's generally accurate pricing. The fair value of $60.53 suggests that VCYT is performing as expected within its competitive landscape, without exhibiting characteristics that would warrant a substantial deviation from its intrinsic valuation.
What this means for investors
For investors considering VCYT, the Fairly Valued assessment, supported by an average quality tier, implies that the current price of $53.25 offers a neutral entry point. While there is a calculated +13.7% to our median fair value of $60.53, significant alpha may hinge on future operational improvements or market shifts that could re-rate VCYT. Our Monte Carlo simulations suggest that at $53.25, VCYT is trading near its equilibrium. FairCurve subscribers can access the full distribution of bear and bull case scenarios to understand the probability of various outcomes. To stay informed, sign up for FairCurve to see the full bear/bull distribution and track VCYT's fair value as new fundamentals are released.
Frequently Asked Questions
Is VCYT overvalued or undervalued right now?
VCYT is Fairly Valued. Its current price of $53.25 is very close to our median fair value (P50) of $60.53, indicating neither significant overvaluation nor undervaluation.
What is the bear case and bull case for VCYT?
Our Monte Carlo simulations generate a full probability distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside. These specific scenarios are available exclusively to FairCurve subscribers.
How does FairCurve calculate VCYT's fair value?
FairCurve calculates VCYT's fair value using sophisticated Monte Carlo simulations that model thousands of forward operational and financial scenarios to derive a comprehensive probability distribution of potential future values.
How can I track VCYT's fair value as it changes?
Add VCYT to your free FairCurve watchlist to receive daily fair-value updates. FairCurve also automatically re-evaluates the stock and updates its fair value instantly when new earnings or significant fundamental data are released.